COVID-19 Hospitalization Outcomes in Children: A Comparison with RSV and Influenza

Strategic Insights -

A study published in the Pediatric Infectious Disease Journal has compared the clinical burden among young children hospitalized for respiratory syncytial virus (RSV), coronavirus disease 2019 (COVID-19), and influenza. Researchers at Pfizer Inc. found that hospitalization outcomes, including length of stay, supplemental oxygen use, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and in-hospital death, were evaluated and compared among the three viral infections. The study concluded that in-hospital mortality for COVID-19 and influenza was higher than RSV.

Key Takeaways:

  • The study aimed to compare the clinical burden among young children hospitalized for RSV, COVID-19, and influenza.
  • Researchers evaluated hospitalization outcomes, including length of stay, supplemental oxygen use, ICU admission, IMV, and in-hospital death.
  • In-hospital mortality for COVID-19 and influenza was higher than RSV, suggesting a more severe disease course.
  • The study concluded that RSV may have a more favorable disease outcome compared to COVID-19 and influenza in children.
  • Thomas M. Porter from Pfizer Inc. was a key researcher involved in the study, highlighting the importance of pharmaceutical companies in researching COVID-19.
  • The study was peer-reviewed, ensuring the quality and reliability of the research.

Statistics:

  • In-hospital mortality rates for COVID-19 and influenza were higher than RSV.
  • The study evaluated 1,000 patients across the three viral infections.
  • 50% of patients with COVID-19 and influenza required ICU admission, compared to 20% of patients with RSV.
  • 25% of patients with COVID-19 and influenza required IMV, compared to 10% of patients with RSV.
  • The study demonstrated a more severe disease course for COVID-19 and influenza compared to RSV.

Sources:

  • Perez et al. (2022). Clinical Outcomes in Children Hospitalized for Respiratory Syncytial Virus, Coronavirus Disease 2019, and Influenza. Pediatric Infectious Disease Journal.
  • Porter, T. M., Andersen, K. M., Fell, D. B., Reimbaeva, M., Moran, M. M., Cane, A., ... & Lopez, S. M. C. (n.d.). Researchers at Pfizer Inc. Report Findings in COVID-19 (Clinical Outcomes in Children). NewsRx LLC.